SINGLE-VENTRICLE
Clinical trials for SINGLE-VENTRICLE explained in plain language.
Never miss a new study
Get alerted when new SINGLE-VENTRICLE trials appear
Sign up with your email to follow new studies for SINGLE-VENTRICLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can exercise rehab help failing fontan hearts?
Disease control Recruiting nowThis study is testing whether a supervised cardiac rehabilitation program can help adults with Fontan heart failure get stronger and feel better. Researchers will compare the rehab program to usual medical care in 50 participants. They will measure changes in daily activity, exer…
Matched conditions: SINGLE-VENTRICLE
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Groundbreaking trial tests Child's own stem cells to strengthen tiny hearts
Disease control Recruiting nowThis study is testing whether injecting a child's own heart stem cells directly into their heart arteries after major reconstructive surgery can help improve their heart's pumping strength and overall function. It involves 40 children born with severe heart defects where only one…
Matched conditions: SINGLE-VENTRICLE
Phase: PHASE3 • Sponsor: Metcela Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New heart scan could improve care for children with rare heart defect
Diagnosis Recruiting nowThis study is testing a new 3D ultrasound imaging technique to better measure heart size and function in children and young adults born with only one working heart pumping chamber. Researchers will compare this new method against the current gold standard, cardiac MRI, to see if …
Matched conditions: SINGLE-VENTRICLE
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated Apr 01, 2026 22:56 UTC
-
Scientists search for clues to stop deadly clots in fragile newborn hearts
Knowledge-focused Recruiting nowThis study aims to understand why newborns with severe congenital heart disease are at high risk for dangerous blood clots after surgery. Researchers will collect blood samples from 10 newborns to analyze tiny molecules that may control clotting. The goal is to uncover the biolog…
Matched conditions: SINGLE-VENTRICLE
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Global watchdog launched for promising heart drug in rare patient group
Knowledge-focused Recruiting nowThis international registry aims to gather real-world information on how a class of drugs called SGLT2 inhibitors is being used in adults born with heart defects. It will track 400 patients who are already prescribed this medication to see how they tolerate it and if it helps imp…
Matched conditions: SINGLE-VENTRICLE
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Scientists track heart drug in tiniest patients
Knowledge-focused Recruiting nowThis study aims to learn how infants born with a severe heart defect called single ventricle disease process the heart medication digoxin. Researchers will collect small blood samples from up to 20 infants during their regular medical care to measure drug levels and heart-related…
Matched conditions: SINGLE-VENTRICLE
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC